PULMONARY ASPERGILLOSIS
Clinical trials for PULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for PULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled antifungal shows promise for lung transplant patients
Disease control CompletedThis study tested a new drug called opelconazole, given as a mist through a nebulizer, to prevent a serious fungal lung infection (aspergillosis) in people who had a lung transplant. The trial involved 102 participants and compared the drug to standard care. The main goal was to …
Matched conditions: PULMONARY ASPERGILLOSIS
Phase: PHASE2 • Sponsor: Pulmocide Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Hidden danger: flu patients in ICU face fungal lung threat
Knowledge-focused CompletedThis study tracked 241 ICU patients with severe influenza to see how many developed a fungal lung infection called IAPA. Researchers collected blood and fluid samples to identify risk factors. The goal is to help doctors spot high-risk patients earlier.
Matched conditions: PULMONARY ASPERGILLOSIS
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC